| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.5 |